Assessment of pyrogenic contaminations with validated human whole-blood assay


Dateien zu dieser Ressource

Prüfsumme: MD5:12ff176195f40622b11ab070097e4c2a

DANESHIAN, Mardas, Sonja von AULOCK, Thomas HARTUNG, 2009. Assessment of pyrogenic contaminations with validated human whole-blood assay. In: Nature protocols. 4(12), pp. 1709-1721. Available under: doi: 10.1038/nprot.2009.159

@article{Daneshian2009Asses-6485, title={Assessment of pyrogenic contaminations with validated human whole-blood assay}, year={2009}, doi={10.1038/nprot.2009.159}, number={12}, volume={4}, journal={Nature protocols}, pages={1709--1721}, author={Daneshian, Mardas and Aulock, Sonja von and Hartung, Thomas} }

<rdf:RDF xmlns:dcterms="" xmlns:dc="" xmlns:rdf="" xmlns:bibo="" xmlns:dspace="" xmlns:foaf="" xmlns:void="" xmlns:xsd="" > <rdf:Description rdf:about=""> <dc:date rdf:datatype="">2011-03-24T17:05:29Z</dc:date> <dc:format>application/pdf</dc:format> <dspace:isPartOfCollection rdf:resource=""/> <dc:contributor>Hartung, Thomas</dc:contributor> <dc:creator>Hartung, Thomas</dc:creator> <dc:contributor>Daneshian, Mardas</dc:contributor> <bibo:uri rdf:resource=""/> <dcterms:abstract xml:lang="eng">We present an internationally validated protocol for the evaluation of pyrogenic contaminations using human whole blood. In the in vitro pyrogen test (IPT) the sample is incubated with fresh or cryopreserved human whole blood, and the proinflammatory cytokine interleukin-1 beta (IL-1 beta) is detected by enzyme-linked immunosorbent assay (ELISA). In addition to detecting pyrogenic contaminations in aqueous samples, e.g., parenteral drugs; adaptations allow the assessment of lipidic, toxic or immunomodulatory substances; detection of low-grade contaminations in large-volume parenterals, e.g., dialysis water and fluids; pyrogenicity assessment of solid materials, e.g., medical devices; and evaluation of airborne pyrogenic burden. In contrast to the rabbit pyrogen test and the limulus amoebocyte lysate (LAL) test, it requires no components of animal origin. In comparison with the LAL, it also detects nonlipopolysaccharide pyrogens. In comparison with other monocyte activation tests it requires no cell preparation steps or cell culture facilities. The procedure takes 21-35 h to complete.</dcterms:abstract> <dcterms:issued>2009</dcterms:issued> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:language>eng</dc:language> <dspace:hasBitstream rdf:resource=""/> <dcterms:available rdf:datatype="">2011-03-24T17:05:29Z</dcterms:available> <dcterms:hasPart rdf:resource=""/> <dcterms:title>Assessment of pyrogenic contaminations with validated human whole-blood assay</dcterms:title> <dcterms:bibliographicCitation>First publ. in: Nature protocols 4 (2009), 12, pp. 1709-1721</dcterms:bibliographicCitation> <dc:rights>terms-of-use</dc:rights> <dcterms:rights rdf:resource=""/> <foaf:homepage rdf:resource="http://localhost:8080/jspui"/> <dcterms:isPartOf rdf:resource=""/> <dc:creator>Aulock, Sonja von</dc:creator> <dc:creator>Daneshian, Mardas</dc:creator> <dc:contributor>Aulock, Sonja von</dc:contributor> </rdf:Description> </rdf:RDF>

Dateiabrufe seit 01.10.2014 (Informationen über die Zugriffsstatistik)

20110126_155629.pdf 269

Das Dokument erscheint in:

KOPS Suche


Mein Benutzerkonto